Novel Antimicrobial Agent Regarded as Next-Generation Antibiotics

Cellbiotech Co, a domestic biotechnology venture company, recently announced that its joint clinical study with a pharmaceutical company from China has produced favorable results from using a novel antimicrobial agent.

Conducted in China, results from the clinical study indicate that the novel agent is effective in selective eradication of and protection against Helicobacter pylori, a type ...